太原早晨 大便带血山西肛泰名医谢坐诊,山西痔疮微创多少钱,山西治疗痔疮的专业医院,肛裂最好的医院山西,山西怎样治便秘,太原老年人便秘怎么办,山西痔疮专科

SAN DIEGO (KGTV) - After moving to San Diego almost three years ago, Derek and Terri Ruff are on a mission to experience everything the city has to offer. “Yes we are, it’s fantastic! We hardly leave the county, there’s just so much to do," said Derek.The couple moved here from New Mexico, and for nine years Derek's colon cancer seemed to be behind them. “I won’t say cancer-free, but I didn’t have any symptoms for years, until last May, whenever I came in for a checkup, and they discovered cancer again," said Derek.It was stage IV metastatic colon cancer.“It’s a lot. It’s a tough diagnosis, it’s really difficult to live through.”After three months of aggressive chemotherapy, Ruff's condition only got worse. His journey brought him to UC San Diego Health's Moores Cancer for a clinical trial, which unfortunately did not work. But he Ruff became a candidate for another trial involving natural killer cells created from stem cells.“These are patients who don’t have a lot of good options in terms of chemotherapy or immunotherapy," said Dr. Sandip Patel, a medical oncologist who is leading the trial at UCSD. Decades of research on natural killer cells have culminated in the new cancer treatment being developed by San Diego-based Fate Therapeutics.Fate is the first to mass produce cancer-killing cells from a type of stem cell called a human-induced pluripotent stem cell (iPSC). "The concept of utilizing the stem cells that are within us, within our blood factory, within our blood marrow, to create a master bank of cells that we can utilize to program in different ways to fight cancer with cellular immunotherapy."The off-the-shelf, iPSC-derived natural killer cell cancer immunotherapy received U.S. Food and Drug Administration approval to move into clinical trials in November 2018. Ruff is the first person in the world to receive the treatment and got his first dose in February.“Being the first is exciting but it was less so hearing that you have stage iv cancer and you don’t have much of a future, and now I feel hopeful, again," said Ruff.While it's too early to tell if the treatment is working, researchers are hopeful this treatment will one day help many cancer patients. 2212

SAN DIEGO (KGTV) - After moving to San Diego almost three years ago, Derek and Terri Ruff are on a mission to experience everything the city has to offer. “Yes we are, it’s fantastic! We hardly leave the county, there’s just so much to do," said Derek.The couple moved here from New Mexico, and for nine years Derek's colon cancer seemed to be behind them. “I won’t say cancer-free, but I didn’t have any symptoms for years, until last May, whenever I came in for a checkup, and they discovered cancer again," said Derek.It was stage IV metastatic colon cancer.“It’s a lot. It’s a tough diagnosis, it’s really difficult to live through.”After three months of aggressive chemotherapy, Ruff's condition only got worse. His journey brought him to UC San Diego Health's Moores Cancer for a clinical trial, which unfortunately did not work. But he Ruff became a candidate for another trial involving natural killer cells created from stem cells.“These are patients who don’t have a lot of good options in terms of chemotherapy or immunotherapy," said Dr. Sandip Patel, a medical oncologist who is leading the trial at UCSD. Decades of research on natural killer cells have culminated in the new cancer treatment being developed by San Diego-based Fate Therapeutics.Fate is the first to mass produce cancer-killing cells from a type of stem cell called a human-induced pluripotent stem cell (iPSC). "The concept of utilizing the stem cells that are within us, within our blood factory, within our blood marrow, to create a master bank of cells that we can utilize to program in different ways to fight cancer with cellular immunotherapy."The off-the-shelf, iPSC-derived natural killer cell cancer immunotherapy received U.S. Food and Drug Administration approval to move into clinical trials in November 2018. Ruff is the first person in the world to receive the treatment and got his first dose in February.“Being the first is exciting but it was less so hearing that you have stage iv cancer and you don’t have much of a future, and now I feel hopeful, again," said Ruff.While it's too early to tell if the treatment is working, researchers are hopeful this treatment will one day help many cancer patients. 2212

SAN DIEGO (KGTV) — After a week of sifting through ashes of the devastating Camp Fire in Northern California, San Diego firefighters are back home tonight. The San Diego Urban Search and Rescue Task Force searched over 1,500 burned structures in the city of Paradise, Calif. Battalion Chief David Gerboth says many did not survive the devastation. Crews were ordered to look for 1- to 5-inch bone fragments of those who might be missing. “We went into a career to save people and we knew going up there that that wasn’t the mission. It was to provide closure for some families,” says Gerboth. The air quality was also a big challenge for firefighters.“There’s a lot of ash, there's a lot of debris. We were constantly wearing respiratory protection," he added.The task force was also away from their loved ones on Thanksgiving. Firefighters say this mission hit home for many of them.“It was definitely a challenge for all of us,” said Brady Holden. “Whatever little problems that you would deal with throughout the day, as you were driving back to the base camp you look around at the devastation, it really put it all into perspective that my problems really aren’t that bad.”The task force had to report all of the structures as clear before leaving. This allowed families to get back to survey the damage and salvage anything they could. 1350

SAN DIEGO (KGTV) — An 86-year-old woman, with underlying health conditions and who had been vaccinated, is the latest flu death in San Diego.The San Diego woman died on Dec. 1 from influenza A and had been vaccinated this season, the County Health and Human Agency said. Officials did not specify what underlying conditions the woman had suffered.This flu season, seven San Diegans have died from the flu. At this time last year, San Diego reported five deaths from the flu.RELATED: Health officials stress getting vaccinated for the flu ASAP“Influenza can be deadly, especially for people with underlying medical conditions and compromised immune systems,” said Wilma Wooten, county public health officer. “Vaccination is the best protection against influenza. The vaccine is safe and effective.”County health officials say residents should still receive a flu vaccine.Last week, 294 flu cases were reported in the region, compared to 202 the previous week. Flu cases are up overall this season, with 1,223 cases reported compared to 650 at this time last year.A list of locations offering flu shots can be found at the county's immunization website or by calling 211 for the county's health hotline.RELATED: Six people arrested during CBP protest over flu services for detaineesCounty health officials also remind locals to help prevent catching the flu by washing their hands thoroughly, using hand sanitizers, stay away from others who may be sick, cleaning commonly touched surfaces, and to avoid touching their face.People with chronic medical conditions, pregnant women, people over 65, and people who live with or care for others who are higher risk are also encouraged to get a flu shot as they face a higher risk of complications from influenza. 1763

SAN DIEGO (KGTV) -- A San Diego woman who participated in a local coronavirus vaccine trial is sharing her experience.Although it’s a blind study, she says she’s convinced she received the vaccine and she hopes her story will encourage others to get vaccinated.During the summer, American biotech company Moderna began some of its phase three trials in San Diego. Leslie Sullivan was one of those patients.“I put my name in the hat and by the end of July I was in getting my first dose,” she told 10News.The vaccine is given in two doses. “It felt like a flu shot and not much in the way of reaction after the first one,” Sullivan added.She says the second time she received the shot, she felt something. “By midnight I spiked a fever, I had chills, it was exactly like how the flu feels.”A day later, Sullivan was back to normal.Sullivan doesn’t know whether or not she got the vaccine, but says based on the symptoms she experienced, she’s almost positive she didn’t get a placebo. She says some people she’s spoken with mistakenly believe that if she got the actual vaccine, she had COVID-19.“The vaccine does not give you COVID this particular one has no live virus in it at all.”Both the Moderna and Pfizer vaccines use MRNA technology, which relies on messenger RNA to essentially trick the body into making antibodies to fight the virus.At some point Sullivan will find out if she did indeed get the vaccine When a vaccine is made available to the public, those who received a placebo will be notified so they can get vaccinated. 1544